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ABSTRACT
The restriction endonuclease Type II R.NmeDI from
Neisseria meningitidis 2120 (serogroup C, ST-11
complex) was characterized. The cloned nmeDIR
gene was expressed in Escherichia coli cells, and
the endonucleolytic and restriction activities of
R.NmeDI were then observed in vitro and in vivo.
The nmeDIR gene consists of 1056bp coding 351 aa
protein with a calculated molecular weight of
M(r)=39000 1000Da. The R.NmeDI enzyme was
purified to apparent homogeneity following over-
expression, using metal affinity chromatography.
This enzyme recognizes a palindrome sequence and
cleaves double-stranded DNA upstream and down-
stream of its recognition sequence (12/7) RCCGGY
(7/12) (R=A/G, Y=C/T) cutting out a 25-bp fragment.
R.NmeDI cleaves in two steps. The enzyme cleaves
the first strand randomly on either side of the
recognition sequence generating an intermediate,
and the second cleavage occurs more slowly and
results in the production of a final reaction product.
The R.NmeDI endonuclease requires two recogni-
tion sequences for effective cleavage. The tetramer
is an active form of the R.NmeDI enzyme.
INTRODUCTION
Type II restriction endonucleases (REases) are a diverse
and very interesting group of proteins (1). They are
components of restriction-modiﬁcation systems (R-M)
that protect bacteria and archaea against invasion by
foreign DNA. The orthodox Type II REases are homo-
dimeric or tetrameric enzymes that speciﬁcally cleave
DNA at deﬁned sites of 4–6bp in length within the
recognition sequence and require Mg
2+ ions for catalysis.
DNA digested with these enzymes produces restriction
fragments with 50 or 30 overhangs or with blunt ends.
However, it has been found that many Type II REases
do not fulﬁll all the criteria for the orthodox Type II
REases (known as Type IIP REases) and possess unique
properties. Taking into account DNA substrate require-
ments, oligomeric status, domains per monomer and site
of cleavage, few additional subtypes of Type II REases
were deﬁned according to their unique properties, e.g. IIA,
IIE, IIS (2).
Type II REases do not have any obvious homology at
the level of their primary sequence but they have a similar
structural core, a common catalytic motif PD...D/EXK
and share a common mechanism of DNA cleavage (2,3).
Currently, the REBASE database includes more than
3600 Type II REases possessing more than 250 distinct
DNA sequence speciﬁcities (rebase.neb.com).
Several R-M systems have been identiﬁed in the
chromosome of Neisseria meningitidis using bioinformatic
methods. However, only a few systems have been experi-
mentally characterized with respect to their recognition
sequence and cleavage site (rebase.neb.com). We have
previously reported that cognate M.NmeDI MTase
recognizes sequence 50 RCCGGB 30 (4). In this article,
we present the characterization of the new restriction
endonuclease R.NmeDI from N. meningitidis 2120. This
enzyme was puriﬁed to homogeneity and its sequence
speciﬁcity was then determined. R.NmeDI recognizes
sequence 50 RCCGGY 30, cleaving double-stranded DNA
on both strands upstream and downstream of the
recognition sequence, releasing 25-bp fragment. We have
also demonstrated that NmeDI R-M system is capable of
in vivo activity.
MATERIALS AND METHODS
NmeDI REase cloning, expression and purification
Escherichia coli ER2566 [F
 l fhuA2 [lon] ompT lacZ::T7
gene 1gal sulA11 i(mcrCmrr)114::IS10R(mcr-73::mini
TN10-TetS)2R(zgb-210::Tn10) (TetS) endA1 [dcm]]
(New England Biolabs) and ER1821 [F
  glnV44
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mrr)114::IS10 (r
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–)] (New England Biolabs) were used
for cloning and expression experiments.
The gene nmeDIM (701899–702555nt; 1276bp) was
ampliﬁed from chromosomal DNA of N. meningitidis 2120
obtained from Dr D.C. Stein (University of Maryland,
USA) and cloned into the XbaI and HindIII sites of
pBAD33, resulting in the formation of plasmid pAK10.
The fragment (700689–701744nt) that encodes the
R.NmeDI REase was ampliﬁed using the same chromo-
somal DNA. This amplicon of 1056bp was cloned into
the NheI and SalI sites of pET28a (Novagen), resulting in
the formation of plasmid pAK11. The nmeDIR gene was
cloned with the nmeDIM gene present on a compatible
plasmid pAK10. The fragment (700689–702555nt;
2318bp) that encodes both the R.NmeDI REase and
M.NmeDI MTase was ampliﬁed from the chromosomal
DNA of N. meningitidis 2120 and cloned into the NcoI and
HindIII sites of pMPMA4V creating plasmid pAK12.
To express R.NmeDI REase, the E. coli ER2566 strain
was transformed with pAK10 and pAK11. The single
colony of the fresh transformants carrying both plasmids
was used to inoculate 5ml LB broth (5) supplemented with
kanamycin (30mg/ml) and chloramphenicol (34mg/ml) for
overnight incubation at 378C. Five milliliters of the
overnight culture was used to inoculate 1l of LB broth
containing the appropriate antibiotics and 1% arabinose.
When the OD600 of the culture reached 0.6, IPTG was
added to a ﬁnal concentration of 1mM and the incubation
was continued at 308C for an additional 12h.
The culture was centrifuged and the bacterial pellet
was resuspended in 10ml buﬀer containing 50mM
NaHPO4, 500mM NaCl, 20mM imidazole, 10mM
b-mercaptoethanol, 0.1% Tween 20 and 100mM PMSF.
After sonication the cellular debris was removed by
centrifugation at 40000g for 1h and the supernatant
was then applied to a 3-ml Ni-NTA Agarose column
previously equilibrated with 100ml of the above buﬀer.
The column was washed with 100ml of buﬀer containing
50mM NaHPO4, 500mM NaCl, 40mM imidazole and
10% glycerol. The proteins were then eluted with
increased concentration of imidazole (50mM to 0.3M)
in the same buﬀer. R.NmeDI REase was eluted at
0.2–0.25M imidazole. The homogeneity of the enzyme
was determined by 10% SDS–PAGE. The total yield of
R.NmeDI protein was 2.5mg/l of induced culture.
Endonuclease activity assay
Endonucleolytic activity in vitro was assayed (6) by
incubation of 0.3pmol DNA with 3.0pmol of puriﬁed
R.NmeDI in a ﬁnal volume of 20ml containing 10mM
Tris–HCl (pH 7.5), 10mM MgCl2 and 0.1mg/ml bovine
serum albumin for 2h at 378C. The cleavage products
were analyzed using 0.7–1.2% TBE agarose, and 5% or
20% neutral polyacrylamide gels. DNA was visualized by
staining with ethidium bromide.
Determination of therecognition sequence and
thecleavage site
The recognition sequence was determined by mapping the
location of cleavage sites on diﬀerent substrate DNAs.
This was achieved by comparison of the proﬁles of
R.NmeDI and R.Cfr10I cleavage restriction fragments,
as well as by the double digestion proﬁle of diﬀerent
plasmid DNAs using both these enzymes.
To determine the cleavage site, phagemid DNA
pBluescript KS II (+) was digested with R.NmeDI and
was then sequenced using pKSRDIf (50 CCACTACG
TGAACCATCACC 30) (221–240nt) and pKSRDIr
(50 AGCGTGACCGCTACACTTG 30) (408–389nt) pri-
mers. Additionally, an extension reaction was carried out
in the presence of four deoxynucleotides, [g-
32P] ATP
labeled primer pKSRDIf or pKSRDIr and pBluescript
KS II (+) as the template. The labeled product of this
reaction was digested with R.NmeDI. Following the
inactivation of the enzyme, the reaction mixture was
divided into half: one-half was stopped immediately, and
the other was treated with the Klenow Fragment at 378C
for 10min in the presence of dNTPs. Both cleavage
products were loaded onto 8% denaturing polyacrylamide
gel along with the products of the sequencing reaction
based on the dideoxynucleotide chain termination method
using pBluescript KS II (+) as the template and the same
primers as for the extension reaction.
Gel filtration
The enzyme samples (250mg) were loaded onto a
Sepharose G200 column (1 50cm) which was equili-
brated with a buﬀer containing 10mM Tris–HCl, pH 7.5,
50mM NaCl and 1mM EDTA. Separation was carried
out at a ﬂow rate of 0.2ml/min. The column was calib-
rated with dextran blue (2MDa), thyroglobulin (670kDa),
R.Cfr10I [calculated tetramer molecular mass 128kDa
(7)], bovine serum albumin (66.2kDa), restriction endo-
nuclease EcoRV [calculated dimer molecular mass
57.2kDa (8)] and lysozyme (14.4kDa). Elution proﬁles
were monitored by measuring absorbance at 280nm and
the speciﬁc  DNA digestion proﬁle for R.Cfr10I,
R.EcoRV and R.NmeDI. For the interpolation of
unknown molecular mass, a linear dependence of the
logarithm of the molecular mass on the elution time was
assumed.
In vivorestriction activity analysis
The restriction activity of E. coli cells carrying the nmeDIR
gene was measured by determination of the plating
eﬃciency of phage vir. The eﬃciency of plaquing (eop)
of vir was calculated as the ratio of plaques formed on
E. coli ER1821-containing plasmid encoding the NmeDI
R-M system (pAK12) to those formed on the E. coli
ER1821 containing pMPMA4V plasmid. The expression
of the genes nmeDIM and nmeDIR was induced by 1%
arabinose.
Other methods
Protein concentrations were measured according to the
method of Lowry (9) using the Bicinchoninic Acid Kit
(Sigma-Aldrich) with bovine serum albumin as a protein
standard. All other methods used routine procedures (5).
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Restriction enzymes, T4 DNA ligase, Pfu DNA polymer-
ase, IPTG (isopropyl-b-D-thiogalactopyranoside) and
DNA and protein markers were purchased from
Fermentas, and used under the conditions recommended
by the manufacturer. Kits for DNA clean-up and plasmid
DNA preparation were purchased from A&A
Biotechnology, Gdansk, Poland. Ni-NTA Agarose was
purchased from Qiagen. All the chemicals were purchased
from Sigma, unless otherwise stated.
Computer analysis
DNA and protein sequences were compared with
GenBank and SWISS-PROT databases on the BLAST
server hosted by the National Center for Biotechnology
Information (www.ncbi.nlm.nih.gov/blast). We used the
genomic sequence of the N. meningitidis strain FAM 18
(www.sanger.ac.uk/Projects/N_meningitidis), which like
strain 2120 belongs to serogroup C (complex ST-11).
RESULTS
Genetic organization of theNmeDI R-M system and
comparison of R.NmeDI REase withother proteins
The nmeDIR gene (1056bp) (accession number AJ
238948) encodes a protein consisting of 351 amino acids.
The nmeDIR gene is associated with the nmeDIM gene,
which encodes M.NmeDI MTase (4). The nmeDIR
and nmeDIM have the same orientation but the
ﬁrst nine codons of the nmeDIR gene overlap with the
30 end of the nmeDIM gene. The amino acid sequence
of R.NmeDI was compared to protein sequences in
GenBank and SWISS-PROT databases, using the
BLAST suite of programs (10). No signiﬁcant homology
was observed with R.Cfr10I or R.BsrFI, which also
recognize the 50 RCCGGY 30 sequence. However, the
amino acid sequence of the R.NmeDI shows: (i) 72%
similarity to a putative type II restriction endonuclease
SusEORF1689P (acc. no. YP_822963.1), whose predicted
recognition sequence is 50 RCCGGY 30 but whose
cleavage site is unknown and (ii) 61% similarity to
PatTORF727P (acc. no YP_660308.1), which is cognate
to M.PatTORF727P MTase, whose predicted recognition
sequence is 50 RCCGGB 30.
Purification of therestriction endonuclease R.NmeDI
The R.NmeDI REase was puriﬁed to apparent homo-
geneity from E. coli ER2566 (pAK10 and pAK11) cells
using metal aﬃnity chromatography and a Ni-NTA
Agarose column. The molecular mass of R.NmeDI was
M(r)=39000 1000Da as estimated from SDS–PAGE
(Figure 1) and was consistent with that predicted on the
basis of the amino acid sequence.
Determination of theoptimal conditions for thein vitro
endonucleolytic activity of R.NmeDI REase
To determine the optimal conditions for the in vitro
endonucleolytic activity of R.NmeDI REase, diﬀerent
buﬀers were tested, taking into account ionic strength, pH,
Mg
2+ ion concentrations and cofactors (ATP, AdoMet).
The maximum activity of the enzyme was observed at
378C in the presence of 10mM Tris–HCl (pH 7.5), 10mM
MgCl2 and 0.1mg/ml BSA in the absence of any salt or
cofactors (data not shown).
Determination of therecognition sequence
R.NmeDI is associated with the cognate M.NmeDI
MTase, which recognizes sequence 50 RCCGGB 30 (4)
and this suggested that R.NmeDI recognizes the same
sequence.
Comparison of the DNA fragments resulting from the
cleavage of pBluescript KS II (+) and pBADHisA by
R.NmeDI and R.Cfr10I both of which recognize the
sequence 50 RCCGGY 30, showed the same banding
pattern except that R.NmeDI fragments were smaller by
 20–30nt (Figure 2A). Double digestion of the pET28a
and pBR322 plasmid DNAs with R.NmeDI and R.Cfr10I
showed the presence of the same fragments as for the
single digestion with R.Cfr10I (Figure 2B). The smaller
size of the DNA fragments of pBluescript KS II (+) and
pBADHisA obtained after cleavage with R.NmeDI
compared to the size of those resulting from digestion
with R.Cfr10I suggested that R.NmeDI cleavage takes
place on either side of the recognition sequence to excise
fragments of 20–50nt. This was conﬁrmed when the
Figure 1. Determination of the molecular mass of R.NmeDI. Puriﬁed
R.NmeDI separated on a 10% SDS–PAGE gel and stained with
Coomassie Brilliant Blue R250. M, The PageRuler
TM Prestained
Protein Ladder (10, 15, 25, 35, 40, 55, 70, 100, 130 and 170kDa)
was used as the protein molecular mass marker.
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Based on the above results we conclude that R.NmeDI
recognizes sequence 50 RCCGGY 30 and cleaves double-
stranded DNA on both strands upstream and down-
stream of its recognition sequence to generate the 25-nt
fragment. It can be concluded that R.NmeDI does not
recognize sequence 50 RCCGGB 30 since the digestion
of pBADHisA or pBR322 should generate 15 and 23
fragments, respectively.
Identification of thecleavage site ofR.NmeDI
The cleavage site of R.NmeDI was determined by
comparing dideoxynucleotide sequencing ladders with:
(i) fragments generated by R.NmeDI cleavage of the
extension reaction products and (ii) the action of the
Klenow Fragment on these digestion products (Figure 3).
To determine the precise cleavage site upstream of the
recognition sequence, [g-
32P] ATP labeled primer
pKSRDIf was used in the extension reaction. The
fragment generated by R.NmeDI digestion of the labeled
product co-migrates with a sequencing ladder band to a
position 13nt before the recognition sequence. This band
corresponds to the nucleotide after which the cleavage
occurs [Figure 3A, lanes (–)]. These results indicate that
the cleavage point upstream of the recognition sequence
occurs 12nt before the 50 RCCGGY 30 sequence. Lane K
in Figure 3A shows the result when the fragment
generated by R.NmeDI digestion of the extension reaction
product was further treated with the Klenow Fragment.
The single band obtained by the action of the Klenow
Fragment co-migrates with the sequencing ladder to a
position 8nt before the recognition sequence. From this
result it can be inferred that the cleavage point is 7nt
before the 50 RCCGGY 30 sequence on the complementary
DNA strand upstream of the recognition sequence.
To determine the precise cleavage site downstream of
the recognition sequence, [g-
32P] ATP labeled primer
pKSRDIr was used in the extension reaction.
As previously described, an analogous analysis of the
results obtained was carried out. The position of the
fragment resulting from R.NmeDI digestion of the labeled
product in relation to the dideoxynucleotide sequencing
ladder indicates that the cleavage site downstream of the
recognition sequence is located 7nt after sequence
50 RCCGGY 30. Analysis of the position of the fragment
generated by R.NmeDI cleavage and further treated with
the Klenow Fragment indicates that the cleavage site
downstream of 50 RCCGGY 30 sequence on the com-
plementary DNA strand occurs 12nt after the recognition
sequence (Figure 3B).
Both reaction products obtained from both extension
reactions after cleavage with R.NmeDI and treatment
with the Klenow Fragment were extended by 5nt,
indicating that R.NmeDI cleaves DNA to generate 5-nt
50 extensions.
Summarizing, the data presented in Figure 3 indicate
that R.NmeDI cleaves both DNA strands symmetrically
upstream and downstream of the recognition sequence
generating 5nt 50 overhangs, thus:
Figure 2. Determination of the recognition sequence of R.NmeDI. (A) Comparison of the plasmid DNA cleavage by R.NmeDI and R.Cfr10I. Lane
1, pBluescript KS II (+) cleaved with R.Cfr10I; lane 2, pBluescript KS II (+) cleaved with R.NmeDI; lane 3, pBADHisA cleaved with R.NmeDI;
lane 4, pBADHisA cleaved with R.Cfr10I. (B) Double digestion of the plasmid DNA with R.Cfr10I and R.NmeDI does not change the banding
proﬁle. Lane 1, pBR322 cleaved with R.Cfr10I and R.NmeDI; lane 2, pBR322 cleaved with R.NmeDI; lane 3, pET28a cleaved with R.NmeDI; lane
4, pET28a cleaved with R.Cfr10I and R.NmeDI. When double digestion was carried out the DNA was ﬁrst digested with R.Cfr10I for 180min and
then with R.NmeDI for 180min. M, DNA molecular weight marker: 10000, 8000, 6000, 5000, 4000, 3500, 3000, 2500, 2000, 1500, 1200, 1000, 900,
800, 700, 600, 500, 400, 300, 200 and 100bp. (C) R.NmeDI cleaves double-stranded DNA on both sides of its recognition sequence. Lane M, DNA
Ladder, Ultra Low Range: 10, 15, 20, 25, 35, 50, 75, 100 and 150bp; lane 1, pBluescript KS II (+) DNA digested with R.NmeDI and
electrophoresed on 20% polyacrylamide gel in TBE buﬀer.
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The quaternary structure of the R.NmeDI enzyme was
determined by gel ﬁltration chromatography. The active
R.NmeDI enzyme was eluted from a Sepharose G200
column at a volume corresponding to a size of  160kDa
(Figure 4). This is consistent with the mass of R.NmeDI in
the tetramer form (calculated tetramer molecular mass
158kDa).
R.NmeDI endonuclease requires tworecognition sequences
foreffective cleavage
Several non-orthodox Type IIP REases are able to cleave
substrate DNA eﬀectively when more than one recogni-
tion sequence is present in the substrate DNA molecules
(11–13). To test the dependence of the R.NmeDI cleavage
rate on the number of recognition sites we compared the
rate of cleavage of pUC18 and pBluescript KS II (+)
containing one and two recognition sites, respectively. The
data presented in Figure 5A show that pUC18 DNA is
cleaved ﬁrst in one strand converting the supercoiled form
of DNA into an open circle form and that cleavage of the
second strand resulting in the full-length form is never
completed.
DNA containing two recognition sites is converted into
the open circle and full-length forms and the ﬁnal reaction
product more rapidly than DNA having only one
recognition site (Figure 5B). The presence of a second
recognition site in trans (pUC18 DNA and oligonucleo-
tides containing one 50 RCCGGY 30 sequence) does not
increase the rate of cleavage (data not shown).
Summarizing, R.NmeDI cleaves supercoiled DNA with
two recognition sequences more quickly and eﬀectively
than DNA with only a single site. Moreover, R.NmeDI
preferentially interacts with two recognition sites in cis
rather than in trans.
R.NmeDI doesnot showsite preference forcleavage
To test whether the enzymatic excision of a small DNA
fragment containing the R.NmeDI recognition sequence is
the consequence of one cleavage event or two independent
cleavage events, we studied the cleavage intermediates.
pBluescript KS II (+) DNA (2961bp) was linearized
with R.Cfr42I (site located at position 661nt) and then
digested for varying lengths of time with R.NmeDI
(one recognized sequence is located at position 328nt
Figure 3. Determination of the cleavage site of R.NmeDI. DNA
sequencing reactions were performed on pBluescript KS II (+) DNA
containing the R.NmeDI recognition site using pKSRDIf or pKSRDIr
primers. Labeled test DNA was generated using the same primers. The
labeled substrate was then digested with R.NmeDI. After inactivating
R.NmeDI, the reaction mixture was divided into two aliquots: one was
mixed with stop solution immediately [lanes ( )]; the other was treated
with Klenow Fragment at room temperature for 10min and then mixed
with stop solution (lane K). The R.NmeDI cleavage products were
loaded onto 8% denatured polyacrylamide gel along with the products
of the sequencing reaction based on the dideoxynucleotide chain
termination method using pBluescript KS II (+) as the template and
the same primers as for the extension reaction. (A) Determination of
the cleavage site of R.NmeDI upstream of the recognition sequence.
(B) Determination of the cleavage site of R.NmeDI downstream of the
recognition sequence.
Figure 4. Determination of the quaternary structure of R.NmeDI.
Estimation of the subunit structure of the native R.NmeDI by gel
ﬁltration on a Sepharose G200 column. The quaternary structure of
R.NmeDI was calculated by interpolation from the standard curve
obtained using dextran blue (2MDa) and proteins with known
molecular masses [thyroglobulin (670kDa), restriction endonuclease
R.Cfr10I (calculate tetramer molecular weight 128kDa), bovine serum
albumin (molecular weight 66.2kDa), restriction endonuclease EcoRV
(calculate dimer molecular weight 57.2kDa) and lysozyme (molecular
weight 14.4kDa)]. The calibration line was calculated by linear
regression using Origin Lab software.
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neously on both sides of the recognition sequence, in
addition to the 25-bp fragment, three fragments of 324,
1138 and 1449bp should be generated. If R.NmeDI
cleaves in two steps, the intermediate fragments of 349,
1163 (two such fragments) and 1474bp should be
generated ﬁrst followed by the ﬁnal products of 324,
1138 and 1449bp created, in addition to the 25-bp
fragment. The results presented in Figure 6 demonstrate
the generation of the 349-bp intermediate cleavage
product. This intermediate fragment is the result of the
initial cleavage of DNA only upstream of recognition
sequence at position 328nt. The larger fragments were not
resolved on this gel. Since the relative ﬂuorescence of all
the fragments obtained is similar, it has been concluded
that cleavage on either side of the recognition sequence
occurs randomly and at equal rates.
The in vivorestriction activity of R.NmeDI REase
The NmeDI R-M system is able to restrict vir phage
in vivo. The eﬃciency of plaque-forming units of the
virulent form of  phage on E. coli ER1821 (pAK12)
encoding the NmeDI R-M system was 1000 times lower
than on control strains E. coli ER1821 containing
pMPMA4V plasmid or E. coli ER1821 which did not
contain a plasmid. The restriction level of bacteriophage
vir by NmeDI R-M is 10
 3 (Table 1).
DISCUSSION
The new restriction endonuclease R.NmeDI encoded by
N. meningitidis 2120 has been characterized in this article.
R.NmeDI is a novel restriction endonuclease that
recognizes the palindromic sequence (12/7) RCCGGY
(7/12) (R=A/G, Y=C/T), and cleaves both DNA
strands upstream and downstream of its recognition
sequence excising small 25-bp fragments. The enzyme in
its active form is a tetramer that cleaves supercoiled DNA
with two recognition sequences more quickly and eﬀec-
tively than plasmid DNA with only a single site. The
reaction rate for plasmid DNA with a single site is not
improved even in the presence of oligonucleotides contain-
ing the 50 RCCGGY 30 sequence. This observation
indicates that the enzyme interacts with two recognition
Figure 5. R.NmeDI activity on plasmids with one or two recognition
sequences. Reactions were carried out with 0.15mM of R.NmeDI and
14.2nM of supercoiled DNAs at 378C. Aliquots were withdrawn at
various times and the reactions were stopped by the addition of 1mlo f
phenol and analyzed on 0.8% TBE agarose gel. pUC18 (A) containing
one R.NmeDI site and pBluescript KS II (+) (B) containing two
R.NmeDI sites were used as a substrate in the reactions. The top panels
show agarose gels of time-course series of enzymatic digestion products
taken from the reaction. All forms of plasmid DNA: supercoiled (ccc)
( - ), open circle (oc) (œ-œ), linear (l) ( - ) are marked by arrows.
Additionally two linear products of digestion of pBluescript KS II (+)
with the enzyme are marked as L1 and L2 (o-o). The graphs show the
analysis of the data produced by ﬁtting to a ﬁrst-order rate equation
using MathCAD software. The DNA in the substrate and product
bands was determined using Gel/ChemiDoc (BioRad) analyzer and
quantiﬁed with the accompanying software package (Quantity One).
The amounts present in individual bands were expressed as a fraction
of the total intensity of DNA as visualized by ethidium bromide
staining.
Figure 6. Analysis of the preference of R.NmeDI cleavage site. A total
of 14.2nM pBluescript KS II (+) was linearized with R.Cfr42I, and
then digested with 0.15mM R.NmeDI for varying lengths of time.
Samples were analyzed on 4% polyacrylamide gel and visualized by
staining with ethidium bromide. M, DNA molecular weight marker:
10000, 8000, 6000, 5000, 4000, 3500, 3000, 2500, 2000, 1500, 1200,
1000, 900, 800, 700, 600, 500, 400, 300, 200 and 100bp.
Table 1. The eﬃciency of plating (eop) of vir phage by the E. coli
ER1821 strain carrying the R-M NmeDI system
Bacterial strain The eﬃciency of
plating of vir
E. coli ER1821 (pMPMA4V::nmeDIM + nmeDIR)1  10
 3
E. coli ER1821 (pMPMA4V)1
E. coli ER1821 1
EOP (eﬃciency of plating): p.f.u. ml
 1 formed on the indicator strain
divided by p.f.u. ml
 1 formed on the propagating strain. Data are
means of at least three independent.
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loop (14). The R.NmeDI enzyme converts a two-site
plasmid into the ﬁnal restriction fragments via the
formation of an intermediate product. This intermediate
product is formed because the DNA is cleaved in two
steps. In the ﬁrst step, DNA is digested on one side of the
recognition sequence, and is followed by a second step in
which cleavage takes place on the other side.
Cleavage on both sides of the recognition sequence is
characteristic of Type IIB systems but all IIB enzymes
studied so far have been found to recognize discontinuous
(usually asymmetric) sites and a distinctive subunit/
domain organization that is not present in the R.NmeDI
enzyme. On the other hand, excision of small 25-bp
fragments by R.NmeDI bears some similarities to the
action of BcgI (15) and HaeIV (16) belonging to Type IIB
system. However, conversely to these enzymes, R.NmeDI
recognizes non-interrupted sequences and ATP and
AdoMet do not have any inﬂuence on its activity.
Type IIB enzymes excise DNA fragments by cutting
either side of their sites and some of them (R.BplI and
R.AloI) (1) recognize palindromic sequences. Some of the
Type IIB systems need no cofactor other than Mg
2+ to
cut DNA, like R.NmeDI (only some IIB enzymes need
AdoMet) and most of the IIB enzymes need two sites to
cut DNA, like R.NmeDI. R.NmeDI may be the prototype
of a new subtype of Type II REases combining the
features of several subtypes of Type II REases. On the one
hand, R.NmeDI is similar to Type IIE or IIF enzymes
that require two copies of the target site for eﬀective
cleavage (2,12). However, in contrast to Type IIF,
R.NmeDI does not cleave both targets coordinately but
carries out the process in two steps. Furthermore, in
contrast to Type IIE, R.NmeDI cleaves dsDNA outside
its recognition sequence and its activity is not stimulated
by oligonucleotide duplexes containing the speciﬁc recog-
nition site. In the case of Type IIE enzymes, one of the
target sequences serves as an allosteric eﬀector for the
eﬀective cleavage of the other recognition site.
Another intriguing possibility is that R.NmeDI is a
Type IIS enzyme but with a palindromic recognition site.
All other Type IIS enzymes recognize asymmetric sites
and cleave at ﬁxed distances from the recognition site on
one side only, the upstream side. However, a Type IIS
enzyme with a palindromic recognition site may bind in
one orientation and excise the upstream DNA and may
then return to the same site, re-bind in the opposite
orientation and excise downstream DNA, thus eventually
releasing the recognition sites on two-site DNA at equal
rates. This is supported by the fact that with the exception
of Type IIS enzymes most restriction enzymes, which use
two sites, destroy the site as they cleave DNA. By cleavage
at positions remote from their sites, the two-site DNA
remaining after IIS action at one site still possesses two
copies of the recognition sequence that can still interact
with each other. Many Type IIS enzymes are monomers in
solution but dimerize during cleavage of DNA, however,
some are known to be tetramers (17). Type IIS systems
generally have two MTases, one for each strand, but a
Type IIS with a palindromic would need only one, as for
example the R-M NmeDI system.
R.NmeDI is an example of a restriction endonuclease,
which like R.Cfr10I and R.BsrFI recognizes sequence 50
RCCGGY 30, but unlike these enzymes has diﬀerent
reaction mechanisms. Examples of similar observations
regarding R-M systems have been reported by Gowers
et al. (18). These authors reported about seven diﬀerent
restriction enzymes with ﬁve diﬀerent reaction mecha-
nisms which all act on the same sequence.
To summarize, R.NmeDI represents a new subtype of
Type II REases because of its unique properties.
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